VH
Virupakshaya Himesh
About Virupakshaya Himesh
Data last updated:
Virupakshaya Himesh is a Whole-Time Director at Bal Pharma Limited (since 2019). The company operates in Pharma. Bal Pharma Limited reported revenue of ₹305 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bal Pharma Limited L85110KA1987PLC008368 | Whole-Time Director | 28 Sep 2019 | 1987 | ₹305 Cr (FY 2025) | Active |
Board colleagues of Virupakshaya Himesh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bheekamchand Mukesh | 11295580 | Bal Pharma Limited | Additional Director |
| Daddanala Venkat Bharath Bhushan | Bal Pharma Limited | Cfo | |
| Jatish Sheth | 00581963 | Bal Pharma Limited | Director |
| Makkigadde Lakshminarayana Shreepada | Bal Pharma Limited | Company Secretary | |
| Nicola Neeladri | 01997936 | Bal Pharma Limited | Director |
| Ravindrakumar Kothari | 03418320 | Bal Pharma Limited | Director |
| Shailesh Siroya | 00048109 | Bal Pharma Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Virupakshaya Himesh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Virupakshaya Himesh
Virupakshaya Himesh currently holds 1 directorship: Bal Pharma Limited (Whole-Time Director, since 28 Sep 2019, revenue ₹305 Cr (FY 2025)).
Virupakshaya Himesh was first appointed on 28 Sep 2019 as Whole-Time Director at Bal Pharma Limited.
The current boards of Virupakshaya Himesh's companies include Bheekamchand Mukesh (Bal Pharma Limited), Daddanala Venkat Bharath Bhushan (Bal Pharma Limited), Jatish Sheth (Bal Pharma Limited), Makkigadde Lakshminarayana Shreepada (Bal Pharma Limited), Nicola Neeladri (Bal Pharma Limited), Ravindrakumar Kothari (Bal Pharma Limited), among others.